Rinda Ubuzima is making significant progress in vaccine development and clinical trials across Rwanda. Our latest Phase III vaccine trials are yielding promising results that could transform healthcare outcomes for millions.
In partnership with the Rwanda Ministry of Health and international collaborators, we have established rigorous protocols that comply with the highest international standards, including ICH-GCP guidelines.
The trials, conducted at our four research sites, involve comprehensive safety monitoring and efficacy assessments. Our dedicated team of research nurses, study physicians, and laboratory personnel works tirelessly to ensure data quality and the safety of participants.
Key findings from our recent malaria vaccine trials indicate significant efficacy rates, offering hope to communities most affected by this preventable disease. These results are currently being prepared for peer-reviewed publication.
Community engagement is central to our clinical trial operations. Through home visits, community sensitization programs, and partnerships with local health facilities, we ensure that research participants are well-informed and supported throughout the trial process.